Highlights

[PHARMA] YoY Quarter Result on 2014-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 14-May-2014
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2014
Quarter 31-Mar-2014  [#1]
Profit Trend QoQ -     25.96%    YoY -     5.84%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 618,294 559,195 471,904 468,672 500,339 446,745 385,328 8.19%
  YoY % 10.57% 18.50% 0.69% -6.33% 12.00% 15.94% -
  Horiz. % 160.46% 145.12% 122.47% 121.63% 129.85% 115.94% 100.00%
PBT 27,777 26,538 38,612 38,159 36,924 42,955 21,792 4.12%
  YoY % 4.67% -31.27% 1.19% 3.34% -14.04% 97.11% -
  Horiz. % 127.46% 121.78% 177.18% 175.11% 169.44% 197.11% 100.00%
Tax -8,519 -8,068 -6,686 -11,513 -11,771 -13,894 -6,193 5.45%
  YoY % -5.59% -20.67% 41.93% 2.19% 15.28% -124.35% -
  Horiz. % 137.56% 130.28% 107.96% 185.90% 190.07% 224.35% 100.00%
NP 19,258 18,470 31,926 26,646 25,153 29,061 15,599 3.57%
  YoY % 4.27% -42.15% 19.82% 5.94% -13.45% 86.30% -
  Horiz. % 123.46% 118.41% 204.67% 170.82% 161.25% 186.30% 100.00%
NP to SH 18,923 18,379 31,794 26,217 24,771 28,685 15,484 3.40%
  YoY % 2.96% -42.19% 21.27% 5.84% -13.64% 85.26% -
  Horiz. % 122.21% 118.70% 205.33% 169.32% 159.98% 185.26% 100.00%
Tax Rate 30.67 % 30.40 % 17.32 % 30.17 % 31.88 % 32.35 % 28.42 % 1.28%
  YoY % 0.89% 75.52% -42.59% -5.36% -1.45% 13.83% -
  Horiz. % 107.92% 106.97% 60.94% 106.16% 112.17% 113.83% 100.00%
Total Cost 599,036 540,725 439,978 442,026 475,186 417,684 369,729 8.37%
  YoY % 10.78% 22.90% -0.46% -6.98% 13.77% 12.97% -
  Horiz. % 162.02% 146.25% 119.00% 119.55% 128.52% 112.97% 100.00%
Net Worth 544,360 515,906 528,173 515,022 484,829 474,161 437,661 3.70%
  YoY % 5.52% -2.32% 2.55% 6.23% 2.25% 8.34% -
  Horiz. % 124.38% 117.88% 120.68% 117.68% 110.78% 108.34% 100.00%
Dividend
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div 10,368 10,354 18,123 10,352 8,825 8,824 - -
  YoY % 0.14% -42.87% 75.07% 17.30% 0.02% 0.00% -
  Horiz. % 117.50% 117.34% 205.38% 117.31% 100.02% 100.00% -
Div Payout % 54.79 % 56.34 % 57.00 % 39.49 % 35.63 % 30.76 % - % -
  YoY % -2.75% -1.16% 44.34% 10.83% 15.83% 0.00% -
  Horiz. % 178.12% 183.16% 185.31% 128.38% 115.83% 100.00% -
Equity
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 544,360 515,906 528,173 515,022 484,829 474,161 437,661 3.70%
  YoY % 5.52% -2.32% 2.55% 6.23% 2.25% 8.34% -
  Horiz. % 124.38% 117.88% 120.68% 117.68% 110.78% 108.34% 100.00%
NOSH 259,219 258,859 258,908 258,805 117,676 117,657 107,007 15.87%
  YoY % 0.14% -0.02% 0.04% 119.93% 0.02% 9.95% -
  Horiz. % 242.24% 241.91% 241.95% 241.86% 109.97% 109.95% 100.00%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 3.11 % 3.30 % 6.77 % 5.69 % 5.03 % 6.51 % 4.05 % -4.30%
  YoY % -5.76% -51.26% 18.98% 13.12% -22.73% 60.74% -
  Horiz. % 76.79% 81.48% 167.16% 140.49% 124.20% 160.74% 100.00%
ROE 3.48 % 3.56 % 6.02 % 5.09 % 5.11 % 6.05 % 3.54 % -0.28%
  YoY % -2.25% -40.86% 18.27% -0.39% -15.54% 70.90% -
  Horiz. % 98.31% 100.56% 170.06% 143.79% 144.35% 170.90% 100.00%
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 238.52 216.02 182.27 181.09 425.18 379.70 360.09 -6.63%
  YoY % 10.42% 18.52% 0.65% -57.41% 11.98% 5.45% -
  Horiz. % 66.24% 59.99% 50.62% 50.29% 118.08% 105.45% 100.00%
EPS 7.30 7.10 12.28 10.13 21.05 24.38 14.47 -10.77%
  YoY % 2.82% -42.18% 21.22% -51.88% -13.66% 68.49% -
  Horiz. % 50.45% 49.07% 84.87% 70.01% 145.47% 168.49% 100.00%
DPS 4.00 4.00 7.00 4.00 7.50 7.50 0.00 -
  YoY % 0.00% -42.86% 75.00% -46.67% 0.00% 0.00% -
  Horiz. % 53.33% 53.33% 93.33% 53.33% 100.00% 100.00% -
NAPS 2.1000 1.9930 2.0400 1.9900 4.1200 4.0300 4.0900 -10.51%
  YoY % 5.37% -2.30% 2.51% -51.70% 2.23% -1.47% -
  Horiz. % 51.34% 48.73% 49.88% 48.66% 100.73% 98.53% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 236.69 214.06 180.65 179.41 191.53 171.02 147.51 8.19%
  YoY % 10.57% 18.49% 0.69% -6.33% 11.99% 15.94% -
  Horiz. % 160.46% 145.12% 122.47% 121.63% 129.84% 115.94% 100.00%
EPS 7.24 7.04 12.17 10.04 9.48 10.98 5.93 3.38%
  YoY % 2.84% -42.15% 21.22% 5.91% -13.66% 85.16% -
  Horiz. % 122.09% 118.72% 205.23% 169.31% 159.87% 185.16% 100.00%
DPS 3.97 3.96 6.94 3.96 3.38 3.38 0.00 -
  YoY % 0.25% -42.94% 75.25% 17.16% 0.00% 0.00% -
  Horiz. % 117.46% 117.16% 205.33% 117.16% 100.00% 100.00% -
NAPS 2.0838 1.9749 2.0219 1.9715 1.8559 1.8151 1.6754 3.70%
  YoY % 5.51% -2.32% 2.56% 6.23% 2.25% 8.34% -
  Horiz. % 124.38% 117.88% 120.68% 117.67% 110.77% 108.34% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 4.8900 5.7600 6.0000 4.4600 8.2600 5.9000 5.7300 -
P/RPS 2.05 2.67 3.29 2.46 1.94 1.55 1.59 4.32%
  YoY % -23.22% -18.84% 33.74% 26.80% 25.16% -2.52% -
  Horiz. % 128.93% 167.92% 206.92% 154.72% 122.01% 97.48% 100.00%
P/EPS 66.99 81.13 48.86 44.03 39.24 24.20 39.60 9.15%
  YoY % -17.43% 66.05% 10.97% 12.21% 62.15% -38.89% -
  Horiz. % 169.17% 204.87% 123.38% 111.19% 99.09% 61.11% 100.00%
EY 1.49 1.23 2.05 2.27 2.55 4.13 2.53 -8.44%
  YoY % 21.14% -40.00% -9.69% -10.98% -38.26% 63.24% -
  Horiz. % 58.89% 48.62% 81.03% 89.72% 100.79% 163.24% 100.00%
DY 0.82 0.69 1.17 0.90 0.91 1.27 0.00 -
  YoY % 18.84% -41.03% 30.00% -1.10% -28.35% 0.00% -
  Horiz. % 64.57% 54.33% 92.13% 70.87% 71.65% 100.00% -
P/NAPS 2.33 2.89 2.94 2.24 2.00 1.46 1.40 8.85%
  YoY % -19.38% -1.70% 31.25% 12.00% 36.99% 4.29% -
  Horiz. % 166.43% 206.43% 210.00% 160.00% 142.86% 104.29% 100.00%
Price Multiplier on Announcement Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 16/05/17 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 13/05/11 -
Price 4.7200 5.6000 6.9100 4.7000 9.2600 5.9000 5.0500 -
P/RPS 1.98 2.59 3.79 2.60 2.18 1.55 1.40 5.94%
  YoY % -23.55% -31.66% 45.77% 19.27% 40.65% 10.71% -
  Horiz. % 141.43% 185.00% 270.71% 185.71% 155.71% 110.71% 100.00%
P/EPS 64.66 78.87 56.27 46.40 43.99 24.20 34.90 10.81%
  YoY % -18.02% 40.16% 21.27% 5.48% 81.78% -30.66% -
  Horiz. % 185.27% 225.99% 161.23% 132.95% 126.05% 69.34% 100.00%
EY 1.55 1.27 1.78 2.16 2.27 4.13 2.87 -9.75%
  YoY % 22.05% -28.65% -17.59% -4.85% -45.04% 43.90% -
  Horiz. % 54.01% 44.25% 62.02% 75.26% 79.09% 143.90% 100.00%
DY 0.85 0.71 1.01 0.85 0.81 1.27 0.00 -
  YoY % 19.72% -29.70% 18.82% 4.94% -36.22% 0.00% -
  Horiz. % 66.93% 55.91% 79.53% 66.93% 63.78% 100.00% -
P/NAPS 2.25 2.81 3.39 2.36 2.25 1.46 1.23 10.58%
  YoY % -19.93% -17.11% 43.64% 4.89% 54.11% 18.70% -
  Horiz. % 182.93% 228.46% 275.61% 191.87% 182.93% 118.70% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

240  626  565  1020 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.16-0.24 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.965-0.035 
 DGSB 0.225+0.01 
 VC 0.05-0.005 
 MTOUCHE 0.05-0.005 
 DATAPRP 0.195-0.025 
 KSTAR 0.415+0.045 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS